Vanda Pharmaceuticals
VNDA
#7387
Rank
โ‚น25.53 B
Marketcap
โ‚น437.91
Share price
3.39%
Change (1 day)
55.50%
Change (1 year)

Revenue for Vanda Pharmaceuticals (VNDA)

Revenue in 2024 (TTM): โ‚น15.16 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น15.35 Billion. In 2023 the company made a revenue of โ‚น16.03 Billion a decrease over the revenue in the year 2022 that were of โ‚น21.05 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vanda Pharmaceuticals from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น15.16 B-5.45%
2023 โ‚น16.03 B-23.81%
2022 โ‚น21.05 B5.26%
2021 โ‚น19.99 B10.19%
2020 โ‚น18.14 B12.03%
2019 โ‚น16.20 B19.98%
2018 โ‚น13.50 B28.11%
2017 โ‚น10.54 B6.23%
2016 โ‚น9.92 B35.83%
2015 โ‚น7.30 B129.81%
2014 โ‚น3.17 B51.87%
2013 โ‚น2.09 B16.81%
2012 โ‚น1.79 B8.33%
2011 โ‚น1.65 B3.38%
2010 โ‚น1.60 B658.3%
2009 โ‚น0.21 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น4.213 T 27,336.24%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น3.447 T 22,349.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.399 T 48,078.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.002 T 25,960.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.694 T 30,468.83%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.271 T 34,224.97%๐Ÿ‡บ๐Ÿ‡ธ USA